Associated Papers
Advancing Precision Oncology in Hereditary Paraganglioma-Pheochromocytoma Syndromes: Integrated Interpretation and Data Sharing of the Germline and Tumor Genomes.
Rana HQ et al.
Cancers, 2024
Role of tissue and circulating microRNAs and DNA as biomarkers in medullary thyroid cancer.
Chiacchiarini M et al.
Pharmacology & Therapeutics, 2021
Ret Receptor Has Distinct Alterations and Functions in Breast Cancer.
Gattelli A et al.
Journal of Mammary Gland Biology and Neoplasia, 2020
Molecular Genetics in the Diagnosis and Biology of Lymphoid Neoplasms.
Lim MS et al.
American Journal of Clinical Pathology, 2019
Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.
Toledo RA et al.
Endocrine-related Cancer, 2015
25425582 (PubMed )
Supplement: supp_ERC-14-0491_Supplementary_table_2.xlsx › Sheet1
[Hereditary thyroid carcinoma and its molecular diagnostics].
Dvořáková S et al.
Ceskoslovenska Patologie, 2014
Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas.
Dvorakova S et al.
Molecular and Cellular Endocrinology, 2008
[Thyroid carcinomas and Hirschsprung's disease--10-year experience with molecular genetic testing of the RET proto-oncogene].
Bendlová B et al.
Vnitrni Lekarstvi, 2006
New multiple somatic mutations in the RET proto-oncogene associated with a sporadic medullary thyroid carcinoma.
Dvoráková S et al.
Thyroid : Official Journal of the American Thyroid Association, 2006
Select a paper to view details